Stijn Franssen

Stijn Franssen is a researcher in the Department of Surgery at Erasmus MC, a leading academic medical center in the Netherlands. His work is centered on surgical oncology, particularly in the treatment of biliary and liver cancers using advanced interventional techniques such as hepatic arterial infusion (HAIP) therapy.

His research interests include cholangiocarcinoma, locoregional cancer therapies, intra-arterial chemotherapy, percutaneous stenting, and perfusion assessment during hepatic surgery. He employs both clinical and imaging-based methodologies to improve patient outcomes, with a focus on survival, technical success, and postoperative complications.

His recent publications show a strong trend toward translational and clinical research in hepatobiliary oncology, particularly in refining HAIP therapy and expanding its applications, such as PSMA-targeted delivery. His work frequently involves multicenter collaboration, especially through the Dutch HAIP Consortium, and appears in high-impact surgical and radiological journals.

Scientific Contributions and Collaborations:

• Active contributor to clinical studies on liver resection and risk modeling
• Key researcher in the development and monitoring of HAIP-based therapies
• Involved in novel applications of nuclear imaging and targeted drug delivery
• Collaborates extensively across institutions in the Netherlands

Stijn Franssen completed his doctoral thesis in 2024, indicating recent completion of a PhD program. While no formal advising role is mentioned, his involvement in major research projects suggests mentorship within collaborative teams. He has not received any publicly listed scientific awards in the provided data. His research is largely embedded within clinical teams focused on surgical oncology and interventional radiology at Erasmus MC.